We suggest that aHMGB1 may promote myocardial fibrosis through activation of Toll-like receptor 4 and downstream NFκB signalling, both of which are known to induce pro-fibrotic cytokine expression and myofibroblast activation. Here, TLR4 is linked to Myocardial fibrosis.